Impulsive actions and choices in laboratory animals and humans: effects of high vs. low dopamine states produced by systemic treatments given to neurologically intact subjects by ValÃ©rie Dâ€™Amour-Horvat & Marco Leyton
BEHAVIORAL NEUROSCIENCE
REVIEW ARTICLE
published: 23 December 2014
doi: 10.3389/fnbeh.2014.00432
Impulsive actions and choices in laboratory animals and
humans: effects of high vs. low dopamine states produced
by systemic treatments given to neurologically intact
subjects
Valérie D’Amour-Horvat1 and Marco Leyton1,2,3*
1 Department of Psychology, McGill University, Montreal, QC, Canada
2 Department of Psychiatry, McGill University, Montreal, QC, Canada
3 Center for Studies in Behavioral Neurobiology, Concordia University, Montreal, QC, Canada
Edited by:
Jozsef Haller, Institute of
Experimental Medicine, Hungary
Reviewed by:
Christelle Baunez, Centre National
de la Recherche Scientifique, France
Juan Dominguez, University of
Texas at Austin, USA
*Correspondence:
Marco Leyton, Department of
Psychiatry, McGill University,
Ludmer Research and Training
Building, 1033 Pine Avenue West,
Room 209, Montreal, H3A 1A1, QC,
Canada
e-mail: marco.leyton@mcgill.ca
Increases and decreases in dopamine (DA) transmission have both been suggested to
influence reward-related impulse-control. The present literature review suggests that, in
laboratory animals, the systemic administration of DA augmenters preferentially increases
susceptibility to premature responding; with continued DA transmission, reward approach
behaviors are sustained. Decreases in DA transmission, in comparison, diminish the appeal
of distal and difficult to obtain rewards, thereby increasing susceptibility to temporal
discounting and other forms of impulsive choice. The evidence available in humans is not
incompatible with this model but is less extensive.
Keywords: impulsivity, compulsivity, addiction, gambling, motivation
OVERVIEW
Both low and high dopamine (DA) states have been proposed
to affect impulse-control. These contrasting views might reflect
different roles in different types of impulsivity. To address this
possibility, we conducted literature searches using PubMed and
Google Scholar, effective to October 20, 2014. The following
terms were entered: impulsive action, stop signal, go/no-go, pre-
mature respon∗, five-choice serial reaction time task (5-CSRT),
differential reinforcement of low rates (DRL) of responding,
simple reaction time task, conditional reaction time, impulsive
choice, delay discount∗, temporal discount∗, effort discount∗,
probability discount∗, Iowa Gambling, gambling, and decision-
making, each entered separately in combination with dopamine,
dopamine agonist, and dopamine antagonist. Papers were then
selected for suitability with a focus on studies conducted with
neurologically intact subjects following acute pharmacologi-
cal challenges administered systemically. Although this focus
ignores regionally specific effects within the brain, it iden-
tifies research with greater immediate clinical relevance with
respect to the routes of drug and medication administration in
humans. The strategy was supplemented by additional publi-
cations noted in the reference lists, and yielded a total of 88
papers. Overall, the reviewed evidence suggests that, in labora-
tory rodents, elevated DA transmission increases susceptibility
to premature responding, while low DA increases preference
for immediately available rewards over larger but more dis-
tal or difficult to attain ones. The evidence in neurologically
intact humans is not incompatible with this view but is less
extensive.
IMPULSIVITY SUBTYPES
Impulse-control is a multifaceted construct (Solanto et al., 2001;
Brewer and Potenza, 2008). One common demarcation sepa-
rates (1) impulsive choice, defined as “actions initiated with-
out due deliberation of other possible options or outcomes”;
and (2) impulsive action, defined as behaviors that are “pre-
mature, mistimed, difficult to suppress and control” (Dalley
et al., 2008). Impulsive action, in turn, might be subdivided
into (a) premature responding; and (b) the inability to inhibit
an initiated response. These subtypes are based on behavioral
and cognitive requirements to perform the tasks used in research
experiments (Winstanley et al., 2006), and disturbances are
seen in a wide range of psychiatric disorders, such as attention
deficit/hyperactivity disorder, pathological gambling and sub-
stance use disorders (American Psychiatric Association, 2013).
There is compelling evidence that DA plays an important, if not
fully understood, role in each of these disorders, and, moreover,
of a causal relationship between DA agonist medication and the
onset of various impulse-control problems such as pathologi-
cal gambling, hypersexuality, compulsive shopping, compulsive
drug-seeking, and binge eating (Gallagher et al., 2007; Dagher and
Robbins, 2009; Moore et al., 2014).
In laboratory animals impulsive action has been assessed most
commonly with the stop-signal task (SST; Logan et al., 1984),
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the go/no-go task (de Wit et al., 2002), the 5-CSRT; Robbins,
2002, the DRL task (e.g., Seiden et al., 1979), and the simple
reaction time task (Amalric and Koob, 1987). Versions of all five
tasks have been used in laboratory rodents and humans, but
the 5-CSRT literatures consist predominantly of animal stud-
ies (Winstanley, 2011). While all tasks can measure premature
responding, the SST and go/no-go tasks were also designed to
measure the ability to inhibit a motor response. The go/no-
go task measures the ability to inhibit responses to inappro-
priate cues, whereas the SST measures the speed at which an
already initiated response can be inhibited (Eagle and Baunez,
2010). The 5-CSRT, DRL and simple reaction time tasks involve
“waiting” before making a response to obtain a reinforcer (see
Box 1 for a more detailed description of these tasks). Impulsive
choice, in comparison, reflects the preference for immediately
available small rewards over larger but more distal ones, and
is commonly evaluated with temporal discounting procedures
such as the delay discounting task (DDT; Ainslie, 1975), effort
discounting paradigms (e.g., Floresco et al., 2008), probabilis-
tic discounting tasks (e.g., St Onge and Floresco, 2009) and
gambling-like tasks, such as the Iowa Gambling Task (IGT;
Bechara et al., 1994; see Box 2 for more detailed descriptions of
these tasks).
While multiple other neurotransmitters also influence perfor-
mance on these tasks (Winstanley et al., 2003; Winstanley, 2011),
the focus of the present review is on the role of DA, both in
laboratory animals and in healthy human subjects. With a few
noted exceptions, we will specifically review studies on the effects
of acutely administered drugs given systemically.
DOPAMINERGIC MANIPULATIONS AND IMPULSIVE
BEHAVIOR
IMPULSIVE ACTION (PREMATURE RESPONDING; INABILITY TO STOP
AN INITIATED BEHAVIOR)
Animal studies
In laboratory rodents, a fairly consistent finding has been that DA
augmenting drugs increase premature responding (see Table 1).
This effect has been observed on the 5-CSRT following the acute
administration of amphetamine (0.15–1.6 mg/kg, i.p.; Cole and
Robbins, 1987; Harrison et al., 1997; van Gaalen et al., 2006b,
2009; Pattij et al., 2007; Loos et al., 2010; Fletcher et al., 2011;
Baarendse and Vanderschuren, 2012; see also Zeeb et al., 2009),
methylphenidate (2.0, 2.5, 5.0 mg/kg, i.p.; Navarra et al., 2008;
Milstein et al., 2010), cocaine (5–20 mg/kg, i.p.; van Gaalen et al.,
2006b; Winstanley et al., 2007; Fletcher et al., 2011), and the
selective DA reuptake inhibitor, GBR 12909 (1.0, 2.5, 5.0, 10.0
mg/kg, i.p.; van Gaalen et al., 2006b; Loos et al., 2010; Baarendse
and Vanderschuren, 2012; Fernando et al., 2012). Two studies
reported a null effect for methylphenidate (0.3–4.0 mg/kg, i.p.) on
premature responding, although a nonsignificant trend of a dose-
dependent increase was found (Fernando et al., 2012; Paterson
et al., 2012). Orally administered modafinil (32, 64, 128 mg/kg)
failed to increase impulsive action on the standard 5-CSRT, but
did so at the two highest doses on a modified version with
shorter stimulus duration and lower stimulus intensity (Waters
et al., 2005). On the DRL, increased premature responding has
BOX 1 | Measures of impulsive action.
1. The five-choice serial reaction time task (5-CSRT; Robbins, 2002)
A visual stimulus is presented at one of five locations, and respond-
ing must be withheld until the stimulus signals that responding
is appropriate. Impulsive behavior is measured by the number of
responses made before the onset of the stimulus.
2. The differential reinforcement of low rates (DRL) of responding
task (e.g., Seiden et al., 1979)
To obtain a reinforcer, subjects are required to withhold from
responding for a fixed period of time and then to respond. Delays
during which subjects are required to withhold from responding
typically range from 10 s (DRL 10) to 72 s (DRL 72). Premature
responses on this task consist of those made before this period
of time has elapsed. Such responses reset the trial and are not
reinforced. In some instances, subjects are required to respond
after a fixed period of time has elapsed, but the response must
occur within a certain delay (e.g., DRL 10–14), otherwise late
responses are not reinforced.
3. The simple reaction time task (Amalric and Koob, 1987)
Each trial begins when subjects press on a lever. They must hold
the lever down for a variable period of time, until a visual or
auditory stimulus is presented. Following the presentation of this
stimulus, subjects must release the lever within a pre-determined
delay. Incorrect trials consist of those during which the lever was
released prior to the stimulus onset (i.e., anticipated or premature
responses) or after the delay has elapsed following the stimulus
onset (i.e., delayed responses).
4. The stop-signal task (SST; Logan et al., 1984)
Subjects initiate a motor response following a go signal, and
reaction times (RT) are determined. On a small proportion of
trials, a stop signal follows the go signal. Sometimes the stop
signal appears well before the subject’s RT limit, thereby providing
sufficient time to inhibit the response. On other trials though the
stop signal occurs very close to when the subject would normally
respond, providing little time to inhibit the behavior. The longer the
interval required to inhibit responses, the longer the stop signal
response time (SSRT), and the poorer the inhibitory control.
5. The go/no-go task (de Wit et al., 2002)
Only one signal is presented per trial. The go signal is much
more frequent than the no-go signal, thus priming subjects to
initiate a motor response. On this task, poor inhibitory control is
quantified by the number of responses on no-go trials (i.e., errors
of commission).
been reported for schedules varying from 10 to 72 s following
acute administration of amphetamine (0.5 mg/kg, s.c.; 0.3–4.0
mg/kg, i.p.; Sanger et al., 1974; Canon and Lippa, 1977; Seiden
et al., 1979; Britton and Koob, 1989; Wenger and Wright, 1990;
van Hest et al., 1992; Richards et al., 1993; Sabol et al., 1995;
Bizot, 1998; Wiley et al., 2000; Ferguson et al., 2001; Liao and
Cheng, 2005; Cheng and Liao, 2007), methylphenidate (2.0–
20.0 mg/kg, i.p.; Seiden et al., 1979; Ferguson et al., 2001),
cocaine (1, 2, 4 mg/kg, i.v.; 10, 20, 40 mg/kg, p.o.; 3–16
mg/kg, i.p.; Woolverton et al., 1978; Wenger and Wright, 1990;
Ma et al., 1999; Wang et al., 2001; Cheng et al., 2006), and
modafinil (64, 128 mg/kg, i.p.; Bizot, 1998). On simple reaction
time tasks, increased premature responding has been observed
in response to amphetamine administration (0.8 mg/kg, s.c.;
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BOX 2 | Measures of impulsive choice.
1. The delay discounting task (DDT; Ainslie, 1975)
Subjects must choose between a small reinforcer delivered imme-
diately and a large reinforcer delivered after a given delay. On
separate trials, the value of the immediate reinforcer or the delay
to obtain the large reinforcer is changed, until subjects reach a
point where both options are chosen equally. This point is called
the indifference point. This step is repeated several times to obtain
multiple points, which yield a hyperbolic discounting curve. The
measure of interest is the steepness of that curve, which is called
the discounting rate, with greater steepness indicating greater
discounting of delayed reinforcers (i.e., impulsive choice). Note
that in studies conducted in human subjects, reinforcers can be
hypothetical or real.
2. Effort discounting tasks (e.g., Floresco et al., 2008)
Subjects must choose between a small reinforcer that can be easily
obtained and a large reinforcer that requires greater effort to obtain.
On separate trials, the value of the easy reinforcer or the amount
of effort required to obtain the large reinforcer is changed, until
subjects reach a point where both options are chosen equally.
This point is called the indifference point. This step is repeated
several times to obtain multiple points, which yield a hyperbolic
discounting curve. The measure of interest is the steepness of that
curve, which is called the discounting rate, with greater steepness
indicating greater effort discounting, meaning that subjects are less
willing to exert effort to obtain the larger reinforcer (i.e., impulsive
choice).
3. Probability discounting tasks (e.g., St Onge and Floresco, 2009)
Subjects must choose between a small reinforcer that is delivered
with greater certainty, and a larger, more uncertain reinforcer that
is delivered according to various probabilities. On separate trials,
the value of the small reinforcer or the probability at which the
large reinforcer is delivered is changed, until subjects reach a point
where both options are chosen equally. This point is called the
indifference point. This step is repeated several times to obtain
multiple points, which yield a hyperbolic discounting curve. The
measure of interest is the steepness of that curve, which is called
the discounting rate, with greater steepness indicating greater
probability discounting, meaning that subjects choose the large
reinforcer despite low probabilities of its delivery (i.e., impulsive
choice).
4. The Iowa Gambling Task (IGT; Bechara et al., 1994)
Subjects are asked to pick cards from four decks, two of which
result in overall gain due to frequent small gains and infrequent
small losses, and the remaining two decks resulting in overall
loss due to frequent large gains but infrequent larger losses. As
subjects are not explicitly told about these contingencies, they
must learn the patterns of wins and losses associated with each
deck, and guide their choice toward the advantageous decks (i.e.,
those providing smaller immediate rewards in prospect of avoiding
a long-term loss) to obtain a positive outcome. Therefore, the
IGT requires learning for optimal performance (Fellows and Farah,
2005).
1.0 mg/kg, i.p.; Baunez et al., 1995; Blokland et al., 2005).
Approach toward the reward persists with sustained increases
in DA transmission (Salamone et al., 1991, 2001; Robinson
and Berridge, 2008; Howe et al., 2013; Leyton and Vezina,
2014).
Dopamine antagonists have the opposite effects of agonists.
Decreased premature responding has been observed on the 5-
CSRT following acute administration of the DA D1 receptor
antagonist, SCH 23390 (0.05, 0.075 mg/kg, i.p. and 10–30 µg/kg,
i.p.; Harrison et al., 1997; van Gaalen et al., 2006b), while D2
antagonists, such as sulpiride (40, 60 mg/kg, i.p.) and eticlo-
pride (0.06–0.1 mg/kg, i.p.), increase the latency to initiate a
response, thus reducing the propensity to impulsive responding
(Harrison et al., 1997; van Gaalen et al., 2006b; see Table 2).
This apparent differential contribution of D1 and D2 receptors
to impulsive responding might reflect their proposed roles in
approach behaviors more generally, with D1 receptor stimulation
thought to induce behavioral activation and heighten the signal-
to-noise salience of appetitive cues while D2 stimulation releases
the “brake” on behavior (Frank, 2005; Tai et al., 2012). Impor-
tantly, re-engaging this hypothesized “brake” with eticlopride also
diminishes the ability of DA augmenters to increase premature
responding (van Gaalen et al., 2006b). On the DRL, the number
of premature responses was diminished by acute doses of SCH
23390 (0.02–0.1 mg/kg, i.p.) and the D2 antagonists raclopride
(0.2–0.5 mg/kg, i.p.; Liao and Cheng, 2005; Cheng and Liao,
2007) and haloperidol (0.25, 0.5 µg/kg, s.c.; 0.16, 0.32 mg/kg, i.p.;
Britton and Koob, 1989; van Hest et al., 1992). On simple reaction
time tasks, several effects have been reported following acute
treatment with DA antagonists. Decreased premature responses
have been observed in response to SCH 23390 (0.025–0.2 mg/kg,
i.p.), raclopride (0.05–0.8 mg/kg, i.p.) and haloperidol (0.05–0.4
mg/kg, i.p.; Marrow et al., 1993). Dopamine antagonists can also
impair performance by lengthening reaction times (RT), resulting
in a greater number of delayed responses while leaving prema-
ture responding intact. These effects have been seen following
administration of eticlopride (0.01, 0.02 mg/kg, s.c.; Smith et al.,
2000), flupenthixol (0.2, 0.4 mg/kg, i.p.; Amalric and Koob, 1987),
and raclopride (50–200 µg/kg, s.c.; 0.05 mg/kg, s.c.; 0.8 mg/kg,
i.p.; Amalric et al., 1993; Marrow et al., 1993; Baunez et al.,
1994, 1995). However, null effects have also been reported in
response to eticlopride (0.01, 0.03 mg/kg, i.p.; Blokland et al.,
2005), SCH 23390 (5, 10, 20 µg/kg, s.c.; Amalric et al., 1993)
and flupenthixol (0.05, 0.1, 0.2, 0.4 mg/kg, i.p.; Marrow et al.,
1993). These slightly discrepant results might reflect differences
in the specifics of the task, such as the delay after the onset of the
stimulus, the behavior performed (e.g., nose poke vs. lever press),
or the effect of these compounds on motivation. For example,
Blokland et al. (2005) found that the highest dose of eticlo-
pride administered in their study (0.03 mg/kg, i.p.) decreased
motivation to obtain food, as assessed by a progressive-ratio
schedule.
In studies using the SST and go/no-go tasks, the results have
been similar. An acute dose of GBR 12909 (5, 10 mg/kg, i.p.)
accelerated both go and stop SST RT leading to an increased
number of premature responses (Bari et al., 2009). Although low
to moderate doses of amphetamine (0.5, 1.0 mg/kg, i.p. in mice;
Loos et al., 2010) and cocaine (5, 10 mg/kg, i.p. in rats; Paine
and Olmstead, 2004) had no effect, a higher dose of cocaine
(15 mg/kg, i.p.) increased premature responding, as indexed by
increased commission errors (responding during no-go trials;
Paine and Olmstead, 2004).
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The ability to inhibit an initiated response is also altered
by DAergic drugs but the pattern of effects differs compared
to those seen on premature responding. In studies using the
SST, the effects of amphetamine, methylphenidate and modafinil
depended on whether the animals had slow or fast inhibitory
responses under placebo. In rats with poor inhibitory control
(slow responders), all three drugs improved performance by
shortening the time required to inhibit an initiated response
(Feola et al., 2000; Eagle and Robbins, 2003; Eagle et al., 2007,
2009). The opposite effect was observed in fast responders (0.3,
1.0 mg/kg modafinil, i.p.; Eagle et al., 2007). Administration of
the D1/D2 receptor antagonist flupenthixol (0.01–0.125 mg/kg,
i.p.), in comparison, had no effect on the ability to inhibit
responses on the SST in either fast or slow responders (Eagle et al.,
2007).
Together then, the weight of evidence from these studies in
laboratory rodents indicates that elevations in DA transmission
can have two main effects on impulsive actions: they increase
premature responding while also improving the ability to inhibit
prepotent responses in impulsive animals.
Human studies
To our knowledge, there are no studies of the effects of DA
augmenters on premature responding in healthy humans. There
is a small literature, though, describing effects on the ability to
inhibit initiated responses (Table 3). In agreement with studies in
laboratory animals, the acute administration of low-to-moderate
doses of oral d-amphetamine (10–20 mg) had differential effects
on SST performance depending on the subject’s baseline perfor-
mance. In individuals with poor baseline inhibitory control (i.e.,
slow stoppers), d-amphetamine improved the ability to inhibit an
initiated response, while having no effect in fast stoppers (de Wit
et al., 2000, 2002). A similar pattern has been observed on the
go/no-go task, where more impulsive subjects at baseline showed
a reduction in the number of commission errors following both
10 and 20 mg of d-amphetamine (de Wit et al., 2002). These
results are consistent with those seen in children and adults
with attention-deficit/hyperactivity disorder, where the ability to
inhibit responses is improved following the administration of oral
methylphenidate (Tannock et al., 1989; Aron et al., 2003). They
are also in accordance with a recent study by Aarts et al. (2014), in
which individuals with greater DA synthesis capacity performed
poorly when they anticipated a large reward on a modified Stroop
task. The authors proposed that DA release in response to the
large rewards may “overdose” an already DA-rich system, and have
detrimental effects on performance. These detrimental effects
would potentially emerge with higher doses of d-amphetamine
in fast stoppers. In one study, methylphenidate administration
(40 mg) did not affect healthy adults’ performance on the SST
or on the go/no-go task, but it reduced intra-individual RT
which is indicative of increased attention (Costa et al., 2013).
The lack of effect on overall performance could be explained
by the low rate of inhibition errors in this particular sample of
participants.
Decreasing DA release, in comparison, using the acute pheny-
lalanine/tyrosine depletion method, has been reported to increase
go/no-go commission errors, particularly in response to reward
cues (Leyton et al., 2007), and diminish the ability to supress
incorrect impulses, as measured with a sensitive electromyo-
graphy index (Ramdani et al., 2014). In the converse experi-
ment, administration of the DA precursor, tyrosine (2.0 g, p.o.),
improved SST performance by reducing the time required to
inhibit initiated responses (Colzato et al., 2014). This effect of
tyrosine might reflect greater cognitive control in the prefrontal
cortex, as the same research group has found that tyrosine
improves performance on a demanding condition of the N-Back
task (Colzato et al., 2013) while tyrosine depletion tended to
reduce N-Back performance in people carrying the low activ-
ity met allele of the gene encoding for the enzyme, catechol-
O-methyltransferase (Kelm and Boettiger, 2013). These effects
on the ability to inhibit prepotent responses, though, have not
been observed consistently in other studies following tyrosine
depletion (McLean et al., 2004; Lythe et al., 2005) or following
administration of d-amphetamine (7.5–15 mg/kg, p.o.; Fillmore
et al., 2005) or the DA agonist, pramipexole (0.25–0.5 mg,
p.o.; Hamidovic et al., 2008). It remains to be tested whether
these divergent findings reflect baseline differences in perfor-
mance or the need for more sensitive measures (Ramdani et al.,
2014).
IMPULSIVE CHOICE (CHOOSING SMALL IMMEDIATELY AVAILABLE
REWARDS OVER DELAYED OR MORE DIFFICULT TO ATTAIN LARGE
REWARDS)
Animal studies
In most studies, the ability to delay responding to receive a larger
reward is disrupted by decreased DA transmission (Cardinal et al.,
2000; Wade et al., 2000; Denk et al., 2005; van Gaalen et al.,
2006a; Floresco et al., 2008; Koffarnus et al., 2011) and improved
by modest increases (see Tables 4, 5). Beneficial effects have
been observed following the administration of methylphenidate
(1.0, 3.0 mg/kg, i.p.; van Gaalen et al., 2006a), cocaine (7.5, 15
mg/kg, i.p.; Winstanley et al., 2007), GBR 12909 (5 mg/kg, i.p.;
van Gaalen et al., 2006a) and amphetamine (0.25–0.6 mg/kg,
i.p.; Cardinal et al., 2000; Isles et al., 2003; Winstanley et al.,
2003; Floresco et al., 2008). Following the administration of
higher doses of amphetamine (0.5–2.3 mg/kg, i.p.; 1.0 mg/kg,
s.c.), the reported results are more variable, and both disruptions
(Charrier and Thiébot, 1996; Evenden and Ryan, 1996; Cardinal
et al., 2000; Isles et al., 2003; Helms et al., 2006; Koffarnus
et al., 2011; Maguire et al., 2014) and improvements have been
described (Wade et al., 2000; Winstanley et al., 2003). A high
dose of pramipexole (0.32 mg/kg, s.c.) increased preference for
the smaller reinforcer (Koffarnus et al., 2011), whereas mod-
erate to high doses of methylphenidate (1.0–4.0 mg/kg, i.p.)
had the opposite effect (Paterson et al., 2012). Interestingly, the
effects of amphetamine and methylphenidate seem to depend,
at least in part, on the order of presentation of delay. Dis-
ruptions have been reported when animals are exposed to the
various delays in descending order (Maguire et al., 2014; Tanno
et al., 2014), whereas improvements (Tanno et al., 2014) or a
null effect (Maguire et al., 2014) have been described when the
delays are presented in ascending order. It has been proposed
that amphetamine and methylphenidate might have induced
perseverative responding early in the sessions when delays were
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presented in descending order, and that continued persevera-
tive responding was responsible for the enhanced choice of the
smaller, immediate reinforcer throughout the sessions (Tanno
et al., 2014).
Lending further support to the association between low DA
and impulsive choice, numerous studies have found that lab-
oratory animals choose smaller, immediate rewards more fre-
quently following the administration of DA antagonists (see
Table 5), including haloperidol (0.1–0.2 mg/kg, i.p.; 0.1 mg/kg,
s.c.; Denk et al., 2005; Koffarnus et al., 2011), raclopride
(80, 120 µg/kg, i.p.; Wade et al., 2000), flupenthixol (0.02, 0.03,
0.125, 0.5 mg/kg; 50, 100 µg/kg, i.p.; Cardinal et al., 2000;
Wade et al., 2000), and SCH 23390 (0.02–0.03 mg/kg, i.p.; 0.01,
0.032 mg/kg, s.c.; van Gaalen et al., 2006a; Koffarnus et al.,
2011). Very low doses of haloperidol (0.01, 0.03 mg/kg, s.c.), in
comparison, had no effect on impulsive choice in response to
standard delays, but decreased impulsive choice in response to
delays that were much shorter than usual (Evenden and Ryan,
1996).
Dopamine antagonists, such as haloperidol (0.1–0.2 mg/kg,
i.p.) and flupenthixol (0.25–0.5 mg/kp, i.p.) also increase effort
discounting (Salamone et al., 1991; Denk et al., 2005; Floresco
et al., 2008) and decrease the willingness to sustain effort as mea-
sured by progressive ratio breakpoints for natural rewards, such as
food (Salamone et al., 2009) and pharmacological rewards, such
as cocaine (Roberts et al., 2013). Interestingly, Cocker et al. (2012)
reported evidence for differential effects of amphetamine on effort
discounting in rats that exert high vs. low effort at baseline. In
hard-working rats, a low dose (0.3 mg/kg, i.p.) increased their
willingness to work to obtain the large reward, but higher doses
(0.6, 1.0 mg/kg, i.p.) had the opposite effect. In the so-called
“slacker” rats, these high doses enhanced their willingness to exert
effort to obtain the large reward. These results are consistent with
Aarts et al. (2014) findings of reduced cognitive control when DA
levels are too high in individuals with greater DA synthesis capac-
ity. It is possible that having too much DA impaired cognitive
control in a way that made the smaller, but immediately available
reward more appealing than the larger reward, which required
greater effort to obtain.
Compared to temporal and effort discounting tasks, the results
overall differ in probabilistic tasks where rats choose between a
smaller but certain reward, and a larger but uncertain reward.
In such tasks, low DA states induced by administration of flu-
penthixol (0.4 mg/kg, i.p.), eticlopride (0.01–0.03 mg/kg), and
SCH 23390 (0.005–0.01 mg/kg, i.p.) decreased risky choices,
even when probabilities of obtaining the larger reward were high
(St Onge and Floresco, 2009; St Onge et al., 2010). In comparison
to these effects of DA antagonists, the administration of small
to moderate doses of amphetamine (0.125–1.0 mg/kg, i.p.) shifts
choice preferences toward larger, more uncertain reward, even
when the probability of delivery is very low (St Onge and Floresco,
2009; St Onge et al., 2010). This effect has been observed when
such probabilities are presented in descending order, while the
opposite was reported when probabilities increased over time
(St Onge et al., 2010). The same research group has also found
that low doses of amphetamine reduced delay (0.25 mg/kg) and
effort discounting (0.125, 0.25 mg/kg, i.p.), but that a higher
dose (0.5 mg/kg, i.p.) increased effort discounting, meaning that
animals were less willing to exert effort to obtain larger rewards
(Floresco et al., 2008).
The above findings suggest that distinct mechanisms underlie
delay, effort, and risk discounting. They further highlight that
methodological differences in task requirements or the order
of presentation of various contingencies can be crucial when
interpreting the effects of DA manipulations. Other differences,
such as the presence of reward cues during the delay, the type
of reinforcer used, and variations in the paradigms, are also
worth considering. It is noteworthy that the standard delay dis-
counting paradigm shares features with premature responding
tasks such as the 5-CSRT, as both assess the ability to wait
in order to get a reinforcer. This is supported by correlations
between levels of delay discounting and premature respond-
ing in the same rats (Robinson et al., 2009). It is therefore
possible that large increases in DA levels, which are known
to induce premature responding, interfered with performance
on DDT, and as such, masked the potential benefits of DA
agonists on the ability to tolerate delays to maximize rewards.
It thus appears that having too little or too much DA can
impair performance on the delay and effort discounting tasks,
whereas high DA might result in greater impulsivity on proba-
bilistic discounting tasks when high probabilities are presented
first.
On a recently developed rat version of the IGT, the rGT,
d-amphetamine (0.25, 0.5, 1.0, 1.5, 2.5 mg/kg, i.p.) increased
preference for smaller but certain rewards, resulting in poorer
overall outcome (Zeeb et al., 2009; Baarendse et al., 2013;
van Enkhuizen et al., 2013), whereas eticlopride (0.01 mg/kg,
i.p.) improved performance by shifting preference toward larger
but riskier rewards (Zeeb et al., 2009). It should be noted
that rats were punished for losses by timeout periods during
which no reward could be earned, which may indicate that
amphetamine exerted its effects by increasing sensitivity to pun-
ishment. This interpretation is consistent with the observa-
tion that d-amphetamine (0.3–1.5 mg/kg, i.p.) dose-dependently
decreased choice of a large but risky reinforcer in a probability
discounting paradigm in which the risky reinforcer was associ-
ated with a mild footshock (Simon et al., 2009, 2011; Mitchell
et al., 2011). Together, the above findings suggest that, in these
studies, amphetamine affects risk aversion more clearly than
reward sensitivity. There are challenges, though, in comparing
rewards and punishments on features such as stimulus salience,
intensity, etc. Other DA augmenters, such as cocaine (5–15
mg/kg, i.p.; Simon et al., 2009), GBR 12909 (2.5–28.5 mg/kg,
i.p.; Baarendse et al., 2013; van Enkhuizen et al., 2013), and
modafinil (16–64 mg/kg, i.p.; van Enkhuizen et al., 2013), as well
as the DA antagonist SCH 23390 (0.001–0.03 mg/kg, i.p.; Zeeb
et al., 2009; Simon et al., 2011), have not significantly affected
performance on the rGT or on the probabilistic task with mild
footshock.
Human studies
The DA—impulsive choice literature in healthy humans remains
quite small (see Table 6). Most of the evidence—direct and
indirect—suggests that low DA states aggravate impulsive choice
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while modest increases improve it (Trifilieff and Martinez, 2014).
For example, transiently decreasing DA synthesis, using the tyro-
sine depletion method, impairs the ability to resist short-term,
large gains despite long-term, larger losses on the IGT (Scarnà
et al., 2005; Sevy et al., 2006), and decreases the willingness
to sustain effort as measured by progressive ratio breakpoints
when subjects work for alcohol (Barrett et al., 2008), tobacco
(Venugopalan et al., 2011) and money (Cawley et al., 2013).
On a guessing game in which probabilities of making the right
decision vary, poor performance has also been observed following
tyrosine depletion when probabilities were low (McLean et al.,
2004), although a lack of effect of tyrosine depletion on prob-
ability discounting has also been reported (Lythe et al., 2005).
Following administration of haloperidol (3 mg, p.o.), perfor-
mance was impaired on a betting game in which there were
no contingencies between responses and outcomes. Specifically,
healthy controls who won money on a given trial subsequently
increased the size of their bet on the next trial (Tremblay et al.,
2011). Thus, greater reward expectancies resulted in increased
risk-taking. However, the same dose of haloperidol did not affect
performance on a slot machine game (Zack and Poulos, 2007),
nor did a smaller dose (1.5 mg/kg, p.o.) affect rates of delay
discounting in healthy adults (Pine et al., 2010). Pramipexole
(0.5 mg, p.o.) increased risky choice on a gambling task follow-
ing unexpected double wins (Riba et al., 2008). Again, reward
expectancies influenced risk-taking. It thus seems that both high
and low DA states enhance risk-taking when a large reward is
expected.
In comparison to these effects of decreasing DA transmission,
healthy volunteers’ tolerance for delayed rewards on the DDT was
increased by a moderate dose of oral d-amphetamine (20 mg; de
Wit et al., 2002), but not following a lower dose of amphetamine
(10 mg, p.o.; de Wit et al., 2002), 150 and 300 mg (p.o.) of the
weak DA reuptake inhibitor bupropion (Acheson and de Wit,
2008), or the direct DA D2 agonist pramipexole (0.25–0.50 mg,
p.o.) (Hamidovic et al., 2008). Low to moderate doses of d-
amphetamine (10, 20 mg, p.o.) also decreased effort discounting,
meaning that participants were more willing to work hard to
obtain large rewards (Wardle et al., 2011). In contrast to the
above findings, administration of the immediate DA precursor,
L-DOPA (150 mg, p.o.), has been reported to increase delay
discounting (Pine et al., 2010), while a smaller dose (100 mg,
p.o.) had no effect on a gambling task in which no feedback
was provided (Symmonds et al., 2013). It has been proposed that
DA might affect decision-making through its effects on learning
from different forms of feedback (Collins and Frank, 2014). The
absence of ongoing feedback during the gambling task might
have prevented L-DOPA from exerting effects, as no learning
was involved. It remains unclear whether the conflicting results
reviewed above reflect lack of specificity of some of the com-
pounds used, different paradigms affecting different aspects of
performance, different behavioral effects from changes in phasic
vs. tonic DA release, spurious findings in a still small literature, or
something else.
In summary, the evidence is less consistent when it comes
to impulsive choice. Animal studies point to dose-dependent
effects, with small increases in DA improving performance
on the DDT and larger doses leading to impairment. In
humans, decreasing DA transmission increases impulsive, effort
discounting, but the effects of DA augmenters and behav-
ioral responses on other tasks are less consistent. In studies
using gambling paradigms, poorer performance is seen fol-
lowing elevated DA transmission in rats and lowered DA in
healthy human subjects. Additional research in humans is needed
where different drugs and a wide range of doses are directly
compared.
SUMMARY AND CONCLUSIONS
It was previously proposed that increased vs. decreased DA trans-
mission might predispose individuals to premature responding vs.
delay discounting (Leyton, 2007). Since then, the animal literature
has grown, and the proposed demarcation stands up well. Studies
in neurologically intact humans, though, remain scarce, and
caution is warranted since the exact effects in humans and rodents
are not always the same. For now, it remains unclear whether these
differences reflect methodology (e.g., different drugs, routes of
administration and tests), neurobiology (e.g., larger, more com-
plex and more dense DA innervation of primate frontal cortex),
or, more simply, the smaller number of studies in healthy human
subjects.
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